These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1635286)

  • 1. Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
    Matsubara M; Taguma Y; Saito T; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):411-6. PubMed ID: 1635286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.
    Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Ishizaki M
    J Lab Clin Med; 1990 Aug; 116(2):206-10. PubMed ID: 2394938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of camostat mesilate on heavy proteinuria in various nephropathies.
    Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Futaki G
    Clin Nephrol; 1989 Sep; 32(3):119-23. PubMed ID: 2791362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
    Onbe T; Makino H; Haramoto T; Wada J; Ogura T; Kumagai I; Murakami K; Fukushima M; Ota Z
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):753-9. PubMed ID: 1770635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of camostat mesilate on urinary protein excretion in three patients with advanced diabetic nephropathy.
    Ikeda Y; Ito H; Hashimoto K
    J Diabetes Complications; 1999; 13(1):56-8. PubMed ID: 10232711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy.
    Onbe T; Makino H; Kumagai I; Haramoto T; Murakami K; Ota Z
    J Diabet Complications; 1991; 5(2-3):167-8. PubMed ID: 1770033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
    N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of camostat mesilate on persistent proteinuria of IgA nephropathy.
    Matsubara M; Taguma Y; Saito T; Yoshinaga K
    Nephron; 1992; 60(2):244-5. PubMed ID: 1553016
    [No Abstract]   [Full Text] [Related]  

  • 9. Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate.
    Takahagi S; Shindo H; Watanabe M; Kameyoshi Y; Hide M
    Acta Derm Venereol; 2010 Jul; 90(4):425-6. PubMed ID: 20574618
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
    Hay U; Ludvik B; Gisinger C; Schernthaner G
    Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
    Krairittichai U; Chaisuvannarat V
    J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
    Kanno Y; Takenaka T; Nakamura T; Suzuki H
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca-antagonist in hypertensive type 2 diabetic patients with overt nephropathy].
    Kuriyama S; Tomonari H; Ohtsuka Y; Ohkido I; Hosoya T
    Nihon Jinzo Gakkai Shi; 2003; 45(4):367-71. PubMed ID: 12806973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J; Banihashemi MA; Ghezlou M; Afshariani R; Salari S; Moini M; Sagheb MM
    Ren Fail; 2010 Jan; 32(2):172-8. PubMed ID: 20199178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
    Ashizawa N; Hashimoto T; Miyake T; Shizuku T; Imaoka T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Apr; 21(4):767-71. PubMed ID: 16677167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
    Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
    Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of camostat mesilate on plasma kallikrein, plasma kininase II and renal kallikrein of man.
    Bönner G; Babst H; Kaufmann W
    Arzneimittelforschung; 1987 May; 37(5):535-7. PubMed ID: 3040018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.
    Okuno M; Akita K; Moriwaki H; Kawada N; Ikeda K; Kaneda K; Suzuki Y; Kojima S
    Gastroenterology; 2001 Jun; 120(7):1784-800. PubMed ID: 11375959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
    Agarwal R; Siva S; Dunn SR; Sharma K
    Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
    Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.